Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis.

Kwo, Paul Y; Puenpatom, Amy; Zhang, Zuoyi; Hui, Siu L; Kelley, Andrea A; Muschi, David

Kwo, Paul Y; Puenpatom, Amy; Zhang, Zuoyi; Hui, Siu L; Kelley, Andrea A; Muschi, David.

Affiliation

Kwo PY; Department of Medicine - Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, United States of America.
Puenpatom A; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Kenilworth, New Jersey, United States of America.
Zhang Z; Department of Medicine, Regenstrief Institute, Indianapolis, Indiana, United States of America.
Hui SL; Department of Biostatistics, Regenstrief Institute, Indianapolis, Indiana, United States of America.
Kelley AA; Data Core Services, Regenstrief Institute, Indianapolis, Indiana, United States of America.
Muschi D; Department of Biostatistics, Indiana University School of Medicine, Indianapolis, United States of America.

PLoS One ; 14(8): e0218759, 2019.

Article de En | MEDLINE | ID: mdl-31437170

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antiviraux / Hépatite C chronique Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: America do norte Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2019 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google